UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 13, 2023
Accession Number:
0001213900-23-044792
Submission Type:
POS AM
CIK:
0001415397
Company Name:
Raphael Pharmaceutical Inc.
File Number:
333-265878